The federal government learned that China had blocked a COVID-19 vaccine shipment meant for clinical trials in Canada, after a collaboration plan between the two countries was just announced, new documents reveal.
On May 12, 2020, the National Research Council of Canada (NRC) announced plans to work with CanSino Biologics Inc., a Chinese company with connections with the Chinese military, to produce the Ad5-nCOV vaccine against COVID-19. CanSino would have been the first company to undertake clinical trials for a COVID-19 candidate vaccine in Canada.
